Clinical Pediatric Emergency Medicine
Volume 10, Issue 4 , Pages 260-271 , December 2009

Adrenal Insufficiency in the Pediatric Emergency Department

  • Rachel Tuuri, MD

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence: Rachel Tuuri, MD, Division of Emergency Medicine, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614.
    • ,
  • Donald Zimmerman, MD

References 

  1. Shulman DI, Palmert MR, Kemp SF, et al. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007;199:e485–94
  2. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009;360:2328–2339
  3. Kovacs J, Votava F, Heinze G, et al. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five Middle European countries. J Clin Endocrinol Metab. 2001;86:2958–2964
  4. Swerdlow A, Higgins CD, Brook CGD, et al. Mortality in patients with congenital adrenal hyperplasia: a cohort study. J Pediatr. 1998;133:516–520
  5. Jaaskelainen J, Voutilainen R. Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr. 2000;89:183–187
  6. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, et al. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006;91:4849–4853
  7. Erichsen MM, Lovas K, Fougner KJ, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol. 2009;160:233–237
  8. Taback SP, Dean HJ. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab. 1996;81:1693–1696
  9. Buchanan CR, Preece MA, Milner RDG. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. Br Med J. 1991;302:824–828
  10. Mills JL, Schonberger LB, Wysowski DK, et al. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr. 2004;144:430–436
  11. Aron DC, Findling JW, Tyrrell JB. Glucocorticoids and adrenal androgens. In:  Gardner DL,  Shoback D editor. Greenspan's basic and clinical endocrinology. 8th ed.. New York (NY): McGraw-Hill; 2007;
  12. Arlt W, Alliolo B. Adrenal insufficiency. Lancet. 2003;31:1881–1893
  13. Kong MF, Jeffcoate W. Eighty-six cases of Addison's disease. Clin Endocrinol. 1994;41:757–761
  14. Willis AC, Vince FP. The prevalence of Addison's disease in Coventry, UK. Postgrad Med J. 1997;73:286–288
  15. Laureti S, Vecchi L, Santeusanio F, et al. Is the prevalence of Addison's disease underestimated?. J Clin Endocrinol Metab. 1999;84:1762
  16. Lovas K, Husebye ES. High prevalence and increasing incidence of Addison's disease in Western Norway. Clin Endocrinol. 2002;56:787–791
  17. Soule S. Addison's disease in Africa: a teaching hospital experience. Clin Endocrinol. 1999;50:115–120
  18. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrinol Rev. 2000;21:245–291
  19. Perry R, Kecha O, Paquette J, et al. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab. 2005;90:3234–3250
  20. Osuwannaratana P, Nimkarn S, Santiprabhob J, et al. The etiologies of adrenal insufficiency in 73 Thai children: 20 years experience. J Med Assoc Thai. 2008;91:1544–1550
  21. Simm PJ, McDonnell CM, Zacharin MR. Primary adrenal insufficiency in childhood and adolescece: advances in diagnosis and management. J Paediatr Child Health. 2004;40:596–599
  22. Bates AS, Van't Hoff W, Jones PJ, et al. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169–1172
  23. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, et al. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab. 2000;85:1420–1425
  24. Regal M, Paramo C, Sierra SM, et al. Prevalence and incidence of hypopituitarism in an adult Caucasian population in Northwestern Spain. Clin Endocrinol. 2001;55:735–740
  25. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. Lancet. 2001;357:425–431
  26. Oberfield SE, Chin D, Uli N, et al. Endocrine late effects of childhood cancers. J Pediatr. 1997;131:S37–41
  27. Benvenga S, Campenni A, Ruggeri RM, et al. Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab. 2000;85:1353–1361
  28. Einaudi S, Bondone C. The effects of head trauma on hypothalamic-pituitary function in children and adolescents. Curr Opin Pediatr. 2007;19:465–470
  29. de Lind van Wijngaarden RF, Otten BJ, Festen DA, et al. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93:1649–1654
  30. Ballal SA, McIntosh P. Endocrinology. In:  Custer JW,  Rau R editor. The Harriet Lane handbook. 18th ed.. Philadelphia (PA): Elsevier Mosby; 2008;
  31. Zelissen PM. Addison patients in the Netherlands: medical report of the survey. The Hague: Dutch Addison Society; 1994;
  32. Stewart PM. The adrenal cortex. In:  Larsen PR,  Kronenberg HM,  Melmed S,  Polosky KS editor. Williams textbook of endocrinology. 11th ed.. Philadelphia (Pa): Saunders; 2008;
  33. White P. Corticosteroid action. In:  Becker KL,  Bilezikian JP,  Hung W, et al. editor. Becker's principles and practice of endocrinology and metabolism. 3rd ed.. Philadelphia (Pa): Lippincott, Williams and Wilkins; 2001;
  34. American College of Medical Genetics . Newborn screening: toward a uniform screening panel and system. Available at: http://mchb.hrsa.gov/screening/Accessed May 12, 2009
  35. Grosse SD, Van Vliet G. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia. Hormone Res. 2007;67:284–291
  36. National Newborn Screening Status Report . Available at: http://genes-r-us.uthscsa.edu/nbsdisorders.pdfAccessed May 12, 2009
  37. Anglin RE, Rosebush PI, Mazurek MF. The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon. J Neuropsychiatr Clin Neurosci. 2006;18:450–459
  38. Tobin MV, Aldridge SA, Morris AL, et al. Gastrointestinal manifestations of Addison's disease. Am J Gastroenterol. 1989;84:1302–1305
  39. Betterle C, Dal Pra C, Mantero F, et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrinol Rev. 2002;23:327–364
  40. Ahonen P, Myllarniemi S, Morris AI, et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829–1836
  41. Jorgensen H. Hypercalcemia in adrenocortical insufficiency. Acta Med Scand. 1973;193:175–179
  42. Nerup J. Addison's disease: clinical studies—a report of 108 cases. Acta Endocrinol. 1974;76:127–141
  43. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med. 1989;321:492–496
  44. Loriaux DL. Tests of adrenocortical function. In:  Becker KL,  Bilezikian JP,  Hung W, et al. editor. Becker's principles and practice of endocrinology and metabolism. 3rd ed.. Philadelphia (Pa): Lippincott, Williams and Wilkins; 2001;
  45. Speiser PW. Congenital adrenal hyperplasia. In:  Becker KL,  Bilezikian JP,  Hung W, et al. editor. Becker's principles and practice of endocrinology and metabolism. 3rd ed.. Philadelphia (Pa): Lippincott, Williams and Wilkins; 2001;
  46. Binder G, Bosk A, Gask M, et al. Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias. Hormone Res. 2004;62:84–87
  47. Giordano R, Picu A, Bonelli L, et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol. 2008;68:935–941
  48. Lomenick JP, Smith WJ. Low-dose adrenocorticotropic hormone stimulation testing in term infants. J Pediatr Endocrinol Metab. 2007;20:773–779
  49. Mushtaq T, Shakur F, Wales JK, et al. Reliability of the low dose synacthen test in children undergoing pituitary function testing. J Pediatr Endocrinol Metab. 2008;21:1129–1132
  50. Magnotti M, Shimshi M. Diagnosing adrenal insufficiency: which test Is best: the 1-ug or the 250 μg cosyntropin stimulation test?. Endocrine Pract. 2008;14:233–238
  51. Shaikh MG, Lewis P, Kirk JM. Thyroxine unmasks Addison's disease. Acta Paediatr. 2004;93:1663–1665
  52. Havard CW, Saldanha VF, Bird R, et al. Adrenal function in hypothyroidism. Br Med J. 1970;1:337–339
  53. Giavoli C, Libe R, Corbetta S, et al. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab. 2004;89:5397–5401
  54. Rosenfield RL, Qin KN. Adrenocortical disorders in infancy and childhood. In:  Becker KL,  Bilezikian JP,  Hung W, et al. editor. Becker's principles and practice of endocrinology and metabolism. 3rd ed.. Philadelphia (Pa): Lippincott, Williams and Wilkins; 2001;
  55. Briars GL, Bailey BJ. Surface area estimation: pocket calculator V nomogram. Arch Dis Child. 1994;70:246–247
  56. Custer JW. Formulary adjunct. In:  Custer JW,  Rau R editor. The Harriet Lane handbook. 18th ed.. Philadelphia (Pa): Elsevier Mosby; 2008;
  57. Loriaux DL. Adrenocortical insufficiency. In:  Becker KL,  Bilezikian JP,  Hung W, et al. editor. Becker's principles and practice of endocrinology and metabolism. 3rd ed.. Philadelphia (Pa): Lippincott, Williams and Wilkins; 2001;
  58. Zora JA, Zimmerman D, Carey TL, et al. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma.. J Allergy Clin Immunol. 1986;9–13
  59. Ducharme FM, Chabot G, Polychronakos C, et al. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function. Pediatrics. 2003;111:376–383
  60. Einaudi S, Bertorello N, Masera N, et al. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50:537–541
  61. Kuperman H, Damiani D, Chrousos GP, et al. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy. J Clin Endocrinol Metab. 2001;86:2993–2996
  62. Lomenick JP, Reifschneider KL, Lucky AW, et al. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol. 2009;145:262–266
  63. Todd GR, Acerini CL, Rose-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87:457–461
  64. Todd GR, Acerini CL, Buck JJ, et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone proprionate. Eur Respir J. 2002;19:1–3
  65. Zollner EW. Hypothalamic-pituitary-adrenal axis suppression I asthmatic children on inhaled corticosteroids (Part 2)—the risk as determined by gold standard adrenal function tests: a systematic review. Pediatr Allergy Immunol. 2007;18:469–474
  66. Zimmerman JJ. A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med. 2007;8:530–539
  67. Bornstein SR, Engeland WC, et al. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab. 2008;19:175–180
  68. Palmieri TL, Levine S, et al. Hypothalamic-pituitary-adrenal axis response to sustained stress after major burn injury in children. J Burn Care Res. 2006;27:742–748
  69. Charmandari E, Kino T, Ichijo T, et al. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab. 2008;93:1563–1572
  70. Hebbar K, Rigby MR, Felner EL, et al. Neuroendocrine dysfunction in pediatric critical illness. Pediatr Crit Care Med. 2009;10:35–40
  71. Menon K, Lawson M. Identification of adrenal insufficiency in pediatric critical illness. Pediatr Crit Care Med. 2007;8:276–278
  72. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med. 2006;174:1319–1326
  73. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37:666–688
  74. Min MUT, Aye M, Shwe TN, et al. Hydorcortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health. 1975;6:573–579
  75. Futrakul P, Poshyachinda M, Mitrakul C, et al. Hemodynamic response to high dose methylprednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement. Southeast Asian J Trop Med Public Health. 1987;18:373–379
  76. Sumarmo , Talogo W, Asrin A, et al. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics. 1982;69:45–49
  77. Tassniyom S, Vasanawathana S, Chirawatkul A, et al. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics. 1993;92:111–115
  78. Slusher T, Gbadero D, Howard C, et al. Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. Pediatr Infect Dis J. 1996;15:579–583
  79. Markovitz BP, Goodman DM, Watson RS, et al. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids?. Pediatr Crit Care Med. 2005;6:270–274
  80. De Dooey JJ, Dijkkamp A, Kneyber MC, et al. Diagnosis and therapy of adrenal insufficiency in pediatric septic shock: from theory to practices. Crit Care Med. 2009;37:796–797
  81. De Jong FH, Mallios C, Jansen C, et al. Etomidate suppresses adrenocortical function by inhibition of 11 beta hydroxylation. J Clin Endocrinol Metab. 1984;59:1143–1147
  82. Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intens Care Med. 2008;34:714–719
  83. Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care. 2006;10:105
  84. Kim TY, Rhee JE, Kim KS, et al. Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock. J Korean Med Sci. 2008;23:988–991
  85. den Brinker M, Hokken-Koelega AC, Hazelzet JA, et al. One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningococcal sepsis. Intens Care Med. 2008;34:163–168
  86. Sacchetti A. Etomidate not worth the risk in septic patients. Ann Emerg Med. 2008;52:14–16
  87. Bloomfield R, Noble DW. Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance. Crit Care. 2006;10:161
  88. Walls RM, Murphy MF. Continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med. 2008;52:13–14
  89. Ching KY, Baum CR. Newer agents for RSI: etomidate and rocuronium. Pediatr Emerg Care. 2009;25:200–207
  90. Ray DC, McKeown DW. Effect of induction agent on vasopressor and steroid use, and outcomes in patients with septic shock. Crit Care. 2007;11:R56
  91. Riche FC, Boutron CM, Valleur P, et al. Adrenal response in patients with septic shock of abdominal origin: relationship to survival. Intens Care Med. 2007;33:1761–1766
  92. Tekwani KL, Watts HF, Rzechula KH, et al. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay. Acad Emerg Med. 2009;16:11–14

PII: S1522-8401(09)00086-X

doi: 10.1016/j.cpem.2009.10.001

Clinical Pediatric Emergency Medicine
Volume 10, Issue 4 , Pages 260-271 , December 2009

Article Tools